International Journal of Biological Sciences
Scope & Guideline
Empowering the Global Community with Life Science Insights
Introduction
Aims and Scopes
- Cancer Biology and Therapeutics:
The journal emphasizes research on the molecular and cellular mechanisms of cancer, including studies on tumorigenesis, metastasis, and therapeutic interventions. - Metabolic Disorders:
Research related to metabolic syndromes, such as diabetes and obesity, and their association with cancer and other diseases is a key focus area, exploring the underlying biological pathways. - Cellular and Molecular Mechanisms:
The journal publishes studies that delve into cellular signaling pathways, gene regulation, and the role of non-coding RNAs in various biological processes. - Immunology and Inflammation:
Research on immune responses, inflammation, and their roles in disease progression, particularly in cancer and metabolic disorders, is prominently featured. - Innovative Therapeutic Strategies:
The journal encourages the exploration of novel therapeutic approaches, including drug repurposing, targeted therapies, and the use of biomaterials in clinical applications. - Extracellular Vesicles and Biomarkers:
The role of extracellular vesicles in cell communication, tumor progression, and as potential biomarkers for diseases, particularly cancer, is a significant area of interest.
Trending and Emerging
- Ferroptosis and Regulated Cell Death:
There is a rising interest in the mechanisms of ferroptosis and other forms of regulated cell death, particularly their roles in cancer and metabolic diseases. - Non-coding RNAs:
Research on non-coding RNAs, including long non-coding RNAs and microRNAs, is gaining traction as they play crucial roles in gene regulation and disease progression. - Multi-Omics Approaches:
The integration of multi-omics data (genomics, proteomics, metabolomics) to understand biological processes and disease mechanisms is increasingly emphasized. - Tumor Microenvironment Interactions:
Studies exploring the interactions between tumor cells and their microenvironment, particularly the role of immune cells and stromal components, are becoming more prominent. - Machine Learning and Bioinformatics:
The application of machine learning and bioinformatics tools for data analysis and to derive insights from complex biological datasets is on the rise. - Immunotherapy and Cancer Vaccines:
Research in immunotherapy, including the development of cancer vaccines and understanding immune evasion mechanisms, is trending as a critical area of focus.
Declining or Waning
- Basic Biological Research:
There appears to be a waning interest in purely basic biological research without direct clinical implications, as the journal increasingly prioritizes studies with clear translational potential. - Traditional Pharmacology:
Research focused on traditional pharmacological approaches is becoming less frequent, with a shift towards exploring novel mechanisms and therapies, particularly those incorporating molecular biology. - In vitro Studies:
The emphasis on in vitro studies without subsequent in vivo validation is declining, as the journal favors studies that incorporate both laboratory and clinical insights. - Animal Models in Cancer Research:
There is a noticeable decrease in the publication of studies solely based on animal models, as the emphasis shifts towards human-related studies and clinical trials. - Epidemiological Studies:
Epidemiological research, particularly those not linked with mechanistic insights or therapeutic implications, is less frequently featured in recent issues.
Similar Journals
CELLULAR AND MOLECULAR LIFE SCIENCES
Unlocking the Secrets of Life at the Cellular LevelCELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.
TRENDS IN CELL BIOLOGY
Exploring the Frontiers of Cellular InnovationTRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Illuminating Cellular Processes Through Open Access ResearchCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
Frontiers in Bioscience-Landmark
Driving Impactful Research in the BiosciencesFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
Cell Communication and Signaling
Connecting Scientists Through Open Access DiscoveriesCell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.
Journal of Cell Communication and Signaling
Advancing the Frontiers of Cellular DialogueThe Journal of Cell Communication and Signaling is a prestigious academic journal published by Springer, focused on advancing the understanding of cellular communication mechanisms and signaling pathways. Since its inception in 2007, this journal has established itself as a leading platform in the field, with a strong impact reflected in its 2023 categorizations: Q1 in Biochemistry, Q2 in Cell Biology, and Q2 in Molecular Biology. Researchers from around the globe rely on its rigorous peer-reviewed articles to gain insights into the complex molecular dialogue that underpins various biological processes. With an ISSN of 1873-9601 and E-ISSN of 1873-961X, the journal is committed to disseminating high-quality research that informs both academic studies and practical applications in biotechnology and medicine. Although not an open access publication, it provides essential resources tailored for professionals, students, and researchers, enhancing their knowledge of critical signaling pathways that drive health and disease. The journal is located in the Netherlands, at VAN GODEWIJCKSTRAAT 30, DORDRECHT, and stands out in the field, boasting impressive ranks among its peers in the Scopus database.
MOLECULAR AND CELLULAR BIOLOGY
Pioneering Research in Cell Biology ExcellenceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
FASEB BioAdvances
Pioneering Discoveries in Physiology and GeneticsFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
FEBS LETTERS
Fostering Knowledge Exchange in Life SciencesFEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.
CELLULAR SIGNALLING
Exploring the Intricacies of Cell BiologyCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.